SEC Filing Summary: Amedica Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Amedica Corporation on August 11, 2016. The report serves to disclose the company's financial results for the second quarter of 2016. The filing incorporates a press release (Exhibit 99.1) by reference to provide the detailed operational and financial data.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached press release (Exhibit 99.1) which is incorporated by reference but not reproduced in the provided text.
Material Changes
The filing announces the release of second-quarter 2016 results. No specific material changes, variances, or comparative data against prior periods are detailed in the body of this 8-K document.
Guidance, Outlook, and Risks
The document does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies. It strictly functions as a notification that the Q2 2016 press release has been issued.
Investor Verification Checklist
- Review Exhibit 99.1 (the attached press release) for actual Q2 2016 revenue and earnings figures.
- Verify the company name discrepancy: The filing metadata lists "Sintx Technologies, Inc.", but the document header and signature block explicitly identify the registrant as "Amedica Corporation."
- Confirm the filing status: The information is deemed "filed" under Section 18 of the Exchange Act, meaning it is subject to liability for false statements.
- Check for subsequent filings to see if the Q2 results were updated or if the company name change (if applicable) was formalized.